AVITA Medical (FRA:51KB) NonCurrent Deferred Liabilities: €3.34 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:51KB AVITA Medical Inc FRA:51KB
65 GF Score
Price €0.65
GF Value €1.48
! 7 Warning Signs
View Full Analysis

What is AVITA Medical NonCurrent Deferred Liabilities?

AVITA Medical FRA:51KB +1.25% 65 NonCurrent Deferred Liabilities is €3.34 Mil as of Mar. 2026. GuruFocus rates FRA:51KB with a GF Score™ of 65/100 and a GF Value™ of €1.48. The stock has 7 warning signs investors should review.

Non-Current Deferred Liabilities represents the non-current portion of obligations, which is a liability that usually would have been paid but is now pas due.

AVITA Medical's non-current deferred liabilities for the quarter that ended in Mar. 2026 was €3.34 Mil.

AVITA Medical NonCurrent Deferred Liabilities Related Terms

AVITA Medical NonCurrent Deferred Liabilities Historical Data

* Premium members only.

The historical data trend for AVITA Medical's NonCurrent Deferred Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

AVITA Medical NonCurrent Deferred Liabilities Chart

AVITA Medical Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Dec22 Dec23 Dec24 Dec25
NonCurrent Deferred Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.89 1.86 3.69 3.15 3.41

AVITA Medical Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
NonCurrent Deferred Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.68 3.56 3.73 3.41 3.34
FRA:51KB
65GF Score
AVITA Medical Inc FRA:51KB
NonCurrent Deferred Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a NonCurrent Deferred Liabilities of €3.34 Mil mean?
AVITA Medical (FRA:51KB) has a NonCurrent Deferred Liabilities of €3.34 Mil as of Mar. 2026. Non-current deferred liabilities represent the company obligations not paid yet not due within the current period. View historical data on AVITA Medical and its competitors.
Is AVITA Medical's NonCurrent Deferred Liabilities too high?
AVITA Medical's current NonCurrent Deferred Liabilities is €3.34 Mil. Overall, AVITA Medical has a GF Score™ of 65/100, reflecting its overall financial health beyond just this single metric.
How does AVITA Medical's NonCurrent Deferred Liabilities compare to MXCT and HYPR?
AVITA Medical's NonCurrent Deferred Liabilities of €3.34 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good NonCurrent Deferred Liabilities for a Medical Devices & Instruments company?
A good NonCurrent Deferred Liabilities depends on the Medical Devices & Instruments industry context. However, NonCurrent Deferred Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high NonCurrent Deferred Liabilities mean?
A high NonCurrent Deferred Liabilities can signal that a stock is expensive relative to its fundamentals. Non-current deferred liabilities represent the company obligations not paid yet not due within the current period. View historical data on AVITA Medical and its competitors. AVITA Medical's current NonCurrent Deferred Liabilities is €3.34 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is AVITA Medical stock overvalued right now?
AVITA Medical (FRA:51KB) has a current NonCurrent Deferred Liabilities of €3.34 Mil. The stock's GF Value™ is €1.48, compared to a current price of €0.65 — trading 56.4% below its estimated fair value. The current NonCurrent Deferred Liabilities is €3.34 Mil. AVITA Medical's overall GF Score™ is 65/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is NonCurrent Deferred Liabilities calculated?
NonCurrent Deferred Liabilities is calculated from a company's financial statements. For AVITA Medical (FRA:51KB), the current NonCurrent Deferred Liabilities is €3.34 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is AVITA Medical (FRA:51KB) Overvalued in 2026?

Based on GuruFocus' analysis, AVITA Medical stock appears to be undervalued. The current stock price of €0.65 is trading 56.4% below its estimated GF Value™ of €1.48.

Key valuation signals for FRA:51KB:

  • NonCurrent Deferred Liabilities: €3.34 Mil
  • GF Value™: €1.48 vs. price of €0.65 (56.4% below fair value)
  • GF Score™: 65/100 with 7 warning signs

No single metric tells the full story. See the FRA:51KB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

AVITA Medical Business Description

Address 28159 Avenue Stanford, Suite 220, Valencia, Santa Clarita, CA, USA, 91355
Avita is largely a single product company. Its RECELL system is an innovative burn treatment device which creates Spray-on Skin from a small skin sample within 30 minutes, thus avoiding or reducing the need for skin grafts. It's approved for the treatment of adult and paediatric patients in the US and an expanded indication for soft-tissue reconstruction. It is currently used in most of the 140 US burn centers. Despite having product approval in Australia, Canada, and China, Avita is not actively marketing in those territories and focussing instead on the US region, although international sales, particularly in Japan, are growing. Avita is domiciled, and has its primary listing, in the US.
65GF Score

Get the complete analysis for FRA:51KB

NonCurrent Deferred Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.65
Price
€1.48
GF Value